In this report, the Asia-Pacific Insomnia Therapy market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Insomnia Therapy for these regions, from 2012 to 2022 (forecast), including China Japan South Korea Taiwan India Southeast Asia Australia Asia-Pacific Insomnia Therapy market competition by top manufacturers/players, with Insomnia Therapy sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including Merck & Co. Inc. Sanofi Pfizer, Inc. Takeda Pharmaceutical Company Ltd. Purdue Pharmaceuticals L.P. Eisai, Co. Ltd. Meda Consumer Healthcare Inc. Pernix Therapeutics Vanda Pharmaceuticals ECR Pharmaceuticals Fidia Farmaceutici Dainippon Sumitomo Biocodex Eli Lilly and Company Ebb Therapeutics On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into Non-pharmacological Therapy Pharmacological Therapy On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including Hospital Ambulatory Surgical Center Home Care If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents Asia-Pacific Insomnia Therapy Market Report 2017 1 Insomnia Therapy Overview 1.1 Product Overview and Scope of Insomnia Therapy 1.2 Classification of Insomnia Therapy by Product Category 1.2.1 Asia-Pacific Insomnia Therapy Market Size (Sales) Comparison by Types (2012-2022) 1.2.2 Asia-Pacific Insomnia Therapy Market Size (Sales) Market Share by Type (Product Category) in 2016 1.2.3 Non-pharmacological Therapy 1.2.4 Pharmacological Therapy 1.3 Asia-Pacific Insomnia Therapy Market by Application/End Users 1.3.1 Asia-Pacific Insomnia Therapy Sales (Volume) and Market Share Comparison by Applications (2012-2022) 1.3.2 Hospital 1.3.3 Ambulatory Surgical Center 1.3.4 Home Care 1.4 Asia-Pacific Insomnia Therapy Market by Region 1.4.1 Asia-Pacific Insomnia Therapy Market Size (Value) Comparison by Region (2012-2022) 1.4.2 China Status and Prospect (2012-2022) 1.4.3 Japan Status and Prospect (2012-2022) 1.4.4 South Korea Status and Prospect (2012-2022) 1.4.5 Taiwan Status and Prospect (2012-2022) 1.4.6 India Status and Prospect (2012-2022) 1.4.7 Southeast Asia Status and Prospect (2012-2022) 1.4.8 Australia Status and Prospect (2012-2022) 1.5 Asia-Pacific Market Size (Value and Volume) of Insomnia Therapy (2012-2022) 1.5.1 Asia-Pacific Insomnia Therapy Sales and Growth Rate (2012-2022) 1.5.2 Asia-Pacific Insomnia Therapy Revenue and Growth Rate (2012-2022) 2 Asia-Pacific Insomnia Therapy Competition by Players/Suppliers, Region, Type and Application 2.1 Asia-Pacific Insomnia Therapy Market Competition by Players/Suppliers 2.1.1 Asia-Pacific Insomnia Therapy Sales Volume and Market Share of Key Players/Suppliers (2012-2017) 2.1.2 Asia-Pacific Insomnia Therapy Revenue and Share by Players/Suppliers (2012-2017) 2.2 Asia-Pacific Insomnia Therapy (Volume and Value) by Type 2.2.1 Asia-Pacific Insomnia Therapy Sales and Market Share by Type (2012-2017) 2.2.2 Asia-Pacific Insomnia Therapy Revenue and Market Share by Type (2012-2017) 2.3 Asia-Pacific Insomnia Therapy (Volume) by Application 2.4 Asia-Pacific Insomnia Therapy (Volume and Value) by Region 2.4.1 Asia-Pacific Insomnia Therapy Sales and Market Share by Region (2012-2017) 2.4.2 Asia-Pacific Insomnia Therapy Revenue and Market Share by Region (2012-2017) 3 China Insomnia Therapy (Volume, Value and Sales Price) 3.1 China Insomnia Therapy Sales and Value (2012-2017) 3.1.1 China Insomnia Therapy Sales Volume and Growth Rate (2012-2017) 3.1.2 China Insomnia Therapy Revenue and Growth Rate (2012-2017) 3.1.3 China Insomnia Therapy Sales Price Trend (2012-2017) 3.2 China Insomnia Therapy Sales Volume and Market Share by Type 3.3 China Insomnia Therapy Sales Volume and Market Share by Application 4 Japan Insomnia Therapy (Volume, Value and Sales Price) 4.1 Japan Insomnia Therapy Sales and Value (2012-2017) 4.1.1 Japan Insomnia Therapy Sales Volume and Growth Rate (2012-2017) 4.1.2 Japan Insomnia Therapy Revenue and Growth Rate (2012-2017) 4.1.3 Japan Insomnia Therapy Sales Price Trend (2012-2017) 4.2 Japan Insomnia Therapy Sales Volume and Market Share by Type 4.3 Japan Insomnia Therapy Sales Volume and Market Share by Application 5 South Korea Insomnia Therapy (Volume, Value and Sales Price) 5.1 South Korea Insomnia Therapy Sales and Value (2012-2017) 5.1.1 South Korea Insomnia Therapy Sales Volume and Growth Rate (2012-2017) 5.1.2 South Korea Insomnia Therapy Revenue and Growth Rate (2012-2017) 5.1.3 South Korea Insomnia Therapy Sales Price Trend (2012-2017) 5.2 South Korea Insomnia Therapy Sales Volume and Market Share by Type 5.3 South Korea Insomnia Therapy Sales Volume and Market Share by Application 6 Taiwan Insomnia Therapy (Volume, Value and Sales Price) 6.1 Taiwan Insomnia Therapy Sales and Value (2012-2017) 6.1.1 Taiwan Insomnia Therapy Sales Volume and Growth Rate (2012-2017) 6.1.2 Taiwan Insomnia Therapy Revenue and Growth Rate (2012-2017) 6.1.3 Taiwan Insomnia Therapy Sales Price Trend (2012-2017) 6.2 Taiwan Insomnia Therapy Sales Volume and Market Share by Type 6.3 Taiwan Insomnia Therapy Sales Volume and Market Share by Application 7 India Insomnia Therapy (Volume, Value and Sales Price) 7.1 India Insomnia Therapy Sales and Value (2012-2017) 7.1.1 India Insomnia Therapy Sales Volume and Growth Rate (2012-2017) 7.1.2 India Insomnia Therapy Revenue and Growth Rate (2012-2017) 7.1.3 India Insomnia Therapy Sales Price Trend (2012-2017) 7.2 India Insomnia Therapy Sales Volume and Market Share by Type 7.3 India Insomnia Therapy Sales Volume and Market Share by Application 8 Southeast Asia Insomnia Therapy (Volume, Value and Sales Price) 8.1 Southeast Asia Insomnia Therapy Sales and Value (2012-2017) 8.1.1 Southeast Asia Insomnia Therapy Sales Volume and Growth Rate (2012-2017) 8.1.2 Southeast Asia Insomnia Therapy Revenue and Growth Rate (2012-2017) 8.1.3 Southeast Asia Insomnia Therapy Sales Price Trend (2012-2017) 8.2 Southeast Asia Insomnia Therapy Sales Volume and Market Share by Type 8.3 Southeast Asia Insomnia Therapy Sales Volume and Market Share by Application 9 Australia Insomnia Therapy (Volume, Value and Sales Price) 9.1 Australia Insomnia Therapy Sales and Value (2012-2017) 9.1.1 Australia Insomnia Therapy Sales Volume and Growth Rate (2012-2017) 9.1.2 Australia Insomnia Therapy Revenue and Growth Rate (2012-2017) 9.1.3 Australia Insomnia Therapy Sales Price Trend (2012-2017) 9.2 Australia Insomnia Therapy Sales Volume and Market Share by Type 9.3 Australia Insomnia Therapy Sales Volume and Market Share by Application 10 Asia-Pacific Insomnia Therapy Players/Suppliers Profiles and Sales Data 10.1 Merck & Co. Inc. 10.1.1 Company Basic Information, Manufacturing Base and Competitors 10.1.2 Insomnia Therapy Product Category, Application and Specification 10.1.2.1 Product A 10.1.2.2 Product B 10.1.3 Merck & Co. Inc. Insomnia Therapy Sales, Revenue, Price and Gross Margin (2012-2017) 10.1.4 Main Business/Business Overview 10.2 Sanofi 10.2.1 Company Basic Information, Manufacturing Base and Competitors 10.2.2 Insomnia Therapy Product Category, Application and Specification 10.2.2.1 Product A 10.2.2.2 Product B 10.2.3 Sanofi Insomnia Therapy Sales, Revenue, Price and Gross Margin (2012-2017) 10.2.4 Main Business/Business Overview 10.3 Pfizer, Inc. 10.3.1 Company Basic Information, Manufacturing Base and Competitors 10.3.2 Insomnia Therapy Product Category, Application and Specification 10.3.2.1 Product A 10.3.2.2 Product B 10.3.3 Pfizer, Inc. Insomnia Therapy Sales, Revenue, Price and Gross Margin (2012-2017) 10.3.4 Main Business/Business Overview 10.4 Takeda Pharmaceutical Company Ltd. 10.4.1 Company Basic Information, Manufacturing Base and Competitors 10.4.2 Insomnia Therapy Product Category, Application and Specification 10.4.2.1 Product A 10.4.2.2 Product B 10.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Sales, Revenue, Price and Gross Margin (2012-2017) 10.4.4 Main Business/Business Overview 10.5 Purdue Pharmaceuticals L.P. 10.5.1 Company Basic Information, Manufacturing Base and Competitors 10.5.2 Insomnia Therapy Product Category, Application and Specification 10.5.2.1 Product A 10.5.2.2 Product B 10.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Sales, Revenue, Price and Gross Margin (2012-2017) 10.5.4 Main Business/Business Overview 10.6 Eisai, Co. Ltd. 10.6.1 Company Basic Information, Manufacturing Base and Competitors 10.6.2 Insomnia Therapy Product Category, Application and Specification 10.6.2.1 Product A 10.6.2.2 Product B 10.6.3 Eisai, Co. Ltd. Insomnia Therapy Sales, Revenue, Price and Gross Margin (2012-2017) 10.6.4 Main Business/Business Overview 10.7 Meda Consumer Healthcare Inc. 10.7.1 Company Basic Information, Manufacturing Base and Competitors 10.7.2 Insomnia Therapy Product Category, Application and Specification 10.7.2.1 Product A 10.7.2.2 Product B 10.7.3 Meda Consumer Healthcare Inc. Insomnia Therapy Sales, Revenue, Price and Gross Margin (2012-2017) 10.7.4 Main Business/Business Overview 10.8 Pernix Therapeutics 10.8.1 Company Basic Information, Manufacturing Base and Competitors 10.8.2 Insomnia Therapy Product Category, Application and Specification 10.8.2.1 Product A 10.8.2.2 Product B 10.8.3 Pernix Therapeutics Insomnia Therapy Sales, Revenue, Price and Gross Margin (2012-2017) 10.8.4 Main Business/Business Overview 10.9 Vanda Pharmaceuticals 10.9.1 Company Basic Information, Manufacturing Base and Competitors 10.9.2 Insomnia Therapy Product Category, Application and Specification 10.9.2.1 Product A 10.9.2.2 Product B 10.9.3 Vanda Pharmaceuticals Insomnia Therapy Sales, Revenue, Price and Gross Margin (2012-2017) 10.9.4 Main Business/Business Overview 10.10 ECR Pharmaceuticals 10.10.1 Company Basic Information, Manufacturing Base and Competitors 10.10.2 Insomnia Therapy Product Category, Application and Specification 10.10.2.1 Product A 10.10.2.2 Product B 10.10.3 ECR Pharmaceuticals Insomnia Therapy Sales, Revenue, Price and Gross Margin (2012-2017) 10.10.4 Main Business/Business Overview 10.11 Fidia Farmaceutici 10.12 Dainippon Sumitomo 10.13 Biocodex 10.14 Eli Lilly and Company 10.15 Ebb Therapeutics 11 Insomnia Therapy Manufacturing Cost Analysis 11.1 Insomnia Therapy Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.1.2 Price Trend of Key Raw Materials 11.1.3 Key Suppliers of Raw Materials 11.1.4 Market Concentration Rate of Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Manufacturing Process Analysis of Insomnia Therapy 12 Industrial Chain, Sourcing Strategy and Downstream Buyers 12.1 Insomnia Therapy Industrial Chain Analysis 12.2 Upstream Raw Materials Sourcing 12.3 Raw Materials Sources of Insomnia Therapy Major Manufacturers in 2016 12.4 Downstream Buyers 13 Marketing Strategy Analysis, Distributors/Traders 13.1 Marketing Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Development Trend 13.2 Market Positioning 13.2.1 Pricing Strategy 13.2.2 Brand Strategy 13.2.3 Target Client 13.3 Distributors/Traders List 14 Market Effect Factors Analysis 14.1 Technology Progress/Risk 14.1.1 Substitutes Threat 14.1.2 Technology Progress in Related Industry 14.2 Consumer Needs/Customer Preference Change 14.3 Economic/Political Environmental Change 15 Asia-Pacific Insomnia Therapy Market Forecast (2017-2022) 15.1 Asia-Pacific Insomnia Therapy Sales Volume, Revenue and Price Forecast (2017-2022) 15.1.1 Asia-Pacific Insomnia Therapy Sales Volume and Growth Rate Forecast (2017-2022) 15.1.2 Asia-Pacific Insomnia Therapy Revenue and Growth Rate Forecast (2017-2022) 15.1.3 Asia-Pacific Insomnia Therapy Price and Trend Forecast (2017-2022) 15.2 Asia-Pacific Insomnia Therapy Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022) 15.2.1 Asia-Pacific Insomnia Therapy Sales Volume and Growth Rate Forecast by Region (2017-2022) 15.2.2 Asia-Pacific Insomnia Therapy Revenue and Growth Rate Forecast by Region (2017-2022) 15.2.3 China Insomnia Therapy Sales, Revenue and Growth Rate Forecast (2017-2022) 15.2.4 Japan Insomnia Therapy Sales, Revenue and Growth Rate Forecast (2017-2022) 15.2.5 South Korea Insomnia Therapy Sales, Revenue and Growth Rate Forecast (2017-2022) 15.2.6 Taiwan Insomnia Therapy Sales, Revenue and Growth Rate Forecast (2017-2022) 15.2.7 India Insomnia Therapy Sales, Revenue and Growth Rate Forecast (2017-2022) 15.2.8 Southeast Asia Insomnia Therapy Sales, Revenue and Growth Rate Forecast (2017-2022) 15.2.9 Australia Insomnia Therapy Sales, Revenue and Growth Rate Forecast (2017-2022) 15.3 Asia-Pacific Insomnia Therapy Sales, Revenue and Price Forecast by Type (2017-2022) 15.3.1 Asia-Pacific Insomnia Therapy Sales Forecast by Type (2017-2022) 15.3.2 Asia-Pacific Insomnia Therapy Revenue Forecast by Type (2017-2022) 15.3.3 Asia-Pacific Insomnia Therapy Price Forecast by Type (2017-2022) 15.4 Asia-Pacific Insomnia Therapy Sales Forecast by Application (2017-2022) 16 Research Findings and Conclusion 17 Appendix 17.1 Methodology/Research Approach 17.1.1 Research Programs/Design 17.1.2 Market Size Estimation 17.1.3 Market Breakdown and Data Triangulation 17.2 Data Source 17.2.1 Secondary Sources 17.2.2 Primary Sources 17.3 Disclaimer